<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37108606</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>18</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Oxidative Damage and Post-COVID Syndrome: A Cross-Sectional Study in a Cohort of Italian Workers.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7445</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24087445</ELocationID><Abstract><AbstractText>In addition to the acute symptoms after infection, patients and society are also being challenged by the long-term effects of COVID-19, known as long COVID. Oxidative stress, as a pivotal point in the pathophysiology of COVID-19, could potentially be also involved in the development of the post-COVID syndrome. The aim of the present study was to evaluate the relationship between changes in oxidative status and the persistence of long-COVID symptoms in workers with a previous mild COVID-19 infection. A cross-sectional study was conducted among 127 employees of an Italian university (80 with a previous COVID-19 infection, and 47 healthy subjects). The TBARS assay was used to detect malondialdehyde serum levels (MDA), while total hydroperoxide (TH) production was measured by a d-ROMs kit. A significant difference in mean serum MDA values was found between previously infected subjects and healthy controls and (4.9 &#xb5;m vs. 2.8 &#xb5;m, respectively). Receiver-operating characteristic (ROC) curves showed high specificity and good sensibility (78.7% and 67.5%, respectively) for MDA serum levels. A random forest classifier identified the hematocrit value, MDA serum levels, and IgG titer against SARS-CoV-2 as features with the highest predictive value in distinguishing 34 long-COVID from 46 asymptomatic post-COVID subjects. Oxidative damage persists in subjects with previous COVID-19 infection, suggesting a possible role of oxidative stress mediators in the pathogenesis of long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stufano</LastName><ForeName>Angela</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9101-7742</Identifier><AffiliationInfo><Affiliation>Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isgr&#xf2;</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9981-4121</Identifier><AffiliationInfo><Affiliation>Department of Translational Biomedicine Neuroscience, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palese</LastName><ForeName>Luigi Leonardo</ForeName><Initials>LL</Initials><Identifier Source="ORCID">0000-0002-3447-1535</Identifier><AffiliationInfo><Affiliation>Department of Translational Biomedicine Neuroscience, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caretta</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Maria</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0553-5309</Identifier><AffiliationInfo><Affiliation>Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovreglio</LastName><ForeName>Piero</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1609-9397</Identifier><AffiliationInfo><Affiliation>Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sardanelli</LastName><ForeName>Anna Maria</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-8535-7601</Identifier><AffiliationInfo><Affiliation>Department of Translational Biomedicine Neuroscience, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TBARS assay</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">malondialdehyde</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">workers</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37108606</ArticleId><ArticleId IdType="pmc">PMC10139201</ArticleId><ArticleId IdType="doi">10.3390/ijms24087445</ArticleId><ArticleId IdType="pii">ijms24087445</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., Carmody L., Rando H., Anzalone A.J., Basson M.D., Bennett T.D., Bergquist T., Boudreau E.A., et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021;74:103722. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. 2021.  [(accessed on 2 January 2022)].  Available online:  WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) Scottish Intercollegiate Guidelines Network (SIGN) Royal College of General Practitioners (RCGP)   COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. NICE; Manchester, UK: 2022.  [(accessed on 7 February 2022)].  Available online:  https://www.nice.org.uk/guidance/ng188/</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber N.H., Kohn J.N., Ogan W.S., Sitapati A., Longhurst C.A., Wang A., Lee S., Hong S., Horton L.E. Deep Dive into the Long Haul: Analysis of Symptom Clusters and Risk Factors for Post-Acute Sequelae of COVID-19 to Inform Clinical Care. Int. J. Environ. Res. Public Health. 2022;15:16841. doi: 10.3390/ijerph192416841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192416841</ArticleId><ArticleId IdType="pmc">PMC9778884</ArticleId><ArticleId IdType="pubmed">36554723</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., et al. COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: A prospective, community-based study. BMJ Open. 2021;11:e048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R., Kanneganti T.D. Innate immunity, cytokine storm, and inflammatory cell death in COVID-19. J. Transl. Med. 2022;20:542. doi: 10.1186/s12967-022-03767-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03767-z</ArticleId><ArticleId IdType="pmc">PMC9682745</ArticleId><ArticleId IdType="pubmed">36419185</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahal A., Kumar A., Singh V., Yadav B., Tiwari R., Chakraborty S., Dhama K. Oxidative stress, prooxidants, and antioxidants: The interplay. BioMed Res. Int. 2014;2014:761264. doi: 10.1155/2014/761264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/761264</ArticleId><ArticleId IdType="pmc">PMC3920909</ArticleId><ArticleId IdType="pubmed">24587990</ArticleId></ArticleIdList></Reference><Reference><Citation>Khomich O.A., Kochetkov S.N., Bartosch B., Ivanov A.V. Redox Biology of Respiratory Viral Infections. Viruses. 2018;10:392. doi: 10.3390/v10080392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10080392</ArticleId><ArticleId IdType="pmc">PMC6115776</ArticleId><ArticleId IdType="pubmed">30049972</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala A., Mu&#xf1;oz M.F., Arg&#xfc;elles S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. 2014;2014:360438. doi: 10.1155/2014/360438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/360438</ArticleId><ArticleId IdType="pmc">PMC4066722</ArticleId><ArticleId IdType="pubmed">24999379</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchini R., Cecchini A.L. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med. Hypotheses. 2020;143:110102. doi: 10.1016/j.mehy.2020.110102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110102</ArticleId><ArticleId IdType="pmc">PMC7357498</ArticleId><ArticleId IdType="pubmed">32721799</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk L.E., Tami A., Hillebrands J.L., den Dunnen W.F.A., de Borst M.H., van der Voort P.H.J., Bulthuis M.L.C., Veloo A.C.M., Wold K.I., Vincenti Gonz&#xe1;lez M.F., et al. Mild Coronavirus Disease 2019 (COVID-19) Is Marked by Systemic Oxidative Stress: A Pilot Study. Antioxidants. 2021;10:2022. doi: 10.3390/antiox10122022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10122022</ArticleId><ArticleId IdType="pmc">PMC8698810</ArticleId><ArticleId IdType="pubmed">34943125</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhail S., Zajac J., Fossum C., Lowater H., McCracken C., Severson N., Laatsch B., Narkiewicz-Jodko A., Johnson B., Liebau J., et al. Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review. Protein J. 2020;39:644&#x2013;656. doi: 10.1007/s10930-020-09935-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10930-020-09935-8</ArticleId><ArticleId IdType="pmc">PMC7587547</ArticleId><ArticleId IdType="pubmed">33106987</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaravelli N., Casola A. Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses. J. Pharm. Pharm. 2014;30:1000141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4288774</ArticleId><ArticleId IdType="pubmed">25584194</ArticleId></ArticleIdList></Reference><Reference><Citation>Medvedev R., Ploen D., Hildt E. HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis. Oxid. Med. Cell. Longev. 2016;2016:9012580. doi: 10.1155/2016/9012580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/9012580</ArticleId><ArticleId IdType="pmc">PMC4756209</ArticleId><ArticleId IdType="pubmed">26955431</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov A.V., Valuev-Elliston V.T., Ivanova O.N., Kochetkov S.N., Starodubova E.S., Bartosch B., Isaguliants M.G. Oxidative Stress during HIV Infection: Mechanisms and Consequences. Oxid. Med. Cell. Longev. 2016;2016:8910396. doi: 10.1155/2016/8910396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/8910396</ArticleId><ArticleId IdType="pmc">PMC5088339</ArticleId><ArticleId IdType="pubmed">27829986</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledur P.F., Karmirian K., Pedrosa C.D.S.G., Souza L.R.Q., Assis-de-Lemos G., Martins T.M., Ferreira J.C.C.G., de Azevedo Reis G.F., Silva E.S., Silva D., et al. Zika virus infection leads to mitochondrial failure, oxidative stress and DNA damage in human iPSC-derived astrocytes. Sci. Rep. 2020;10:1218. doi: 10.1038/s41598-020-57914-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-57914-x</ArticleId><ArticleId IdType="pmc">PMC6985105</ArticleId><ArticleId IdType="pubmed">31988337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J.Y., Oh E., Kim Y., Jung W.W., Kim H.S., Lee J., Sul D. Enhanced oxidative damage to DNA, lipids, and proteins and levels of some antioxidant enzymes, cytokines, and heat shock proteins in patients infected with influenza H1N1 virus. Acta Virol. 2014;58:253&#x2013;260. doi: 10.4149/av_2014_03_253.</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/av_2014_03_253</ArticleId><ArticleId IdType="pubmed">25283860</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer C.S. Innate metabolic responses against viral infections. Nat. Metab. 2022;10:1245&#x2013;1259. doi: 10.1038/s42255-022-00652-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-022-00652-3</ArticleId><ArticleId IdType="pubmed">36266542</ArticleId></ArticleIdList></Reference><Reference><Citation>Medini H., Zirman A., Mishmar D. Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring toward glycolysis. iScience. 2021;24:103471. doi: 10.1016/j.isci.2021.103471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103471</ArticleId><ArticleId IdType="pmc">PMC8599136</ArticleId><ArticleId IdType="pubmed">34812416</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Martin J.C. Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages. Nat. Rev. Immunol. 2020;20:355&#x2013;362. doi: 10.1038/s41577-020-0331-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Thambiraja T.S., Karuppanan K., Subramaniam G. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. J. Med. Virol. 2022;94:1641&#x2013;1649. doi: 10.1002/jmv.27526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27526</ArticleId><ArticleId IdType="pubmed">34914115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosanovic T., Sagic D., Djukic V., Pljesa-Ercegovac M., Savic-Radojevic A., Bukumiric Z., Lalosevic M., Djordjevic M., Coric V., Simic T. Time Course of Redox Biomarkers in COVID-19 Pneumonia: Relation with Inflammatory, Multiorgan Impairment Biomarkers and CT Findings. Antioxidants. 2021;10:1126. doi: 10.3390/antiox10071126.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10071126</ArticleId><ArticleId IdType="pmc">PMC8301049</ArticleId><ArticleId IdType="pubmed">34356359</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadotti A.C., Lipinski A.L., Vasconcellos F.T., Marqueze L.F., Cunha E.B., Campos A.C., Oliveira C.F., Amaral A.N., Baena C.P., Telles J.P., et al. Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Radic. Biol. Med. 2021;165:184&#x2013;190. doi: 10.1016/j.freeradbiomed.2021.01.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.01.044</ArticleId><ArticleId IdType="pmc">PMC7846460</ArticleId><ArticleId IdType="pubmed">33524532</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehri F., Rahbar A.H., Ghane E.T., Souri B., Esfahani M. Changes in oxidative markers in COVID-19 patients. Arch. Med. Res. 2022;52:843&#x2013;849. doi: 10.1016/j.arcmed.2021.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.06.004</ArticleId><ArticleId IdType="pmc">PMC8180845</ArticleId><ArticleId IdType="pubmed">34154831</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi Y. Roles of Oxidative Stress and Inflammation in Vascular Endothelial Dysfunction-Related Disease. Antioxidants. 2022;11:1958. doi: 10.3390/antiox11101958.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11101958</ArticleId><ArticleId IdType="pmc">PMC9598825</ArticleId><ArticleId IdType="pubmed">36290681</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.H., Chen H.X., Y&#xfc; G., Peng C.C., Peng R.Y. Curcumin-Protected PC12 Cells Against Glutamate-Induced Oxidative Toxicity. Food Technol. Biotechnol. 2014;52:468&#x2013;478. doi: 10.17113/ftb.52.04.14.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.17113/ftb.52.04.14.3622</ArticleId><ArticleId IdType="pmc">PMC5079148</ArticleId><ArticleId IdType="pubmed">27904320</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalo H., Brieva L., Tatzber F., Jov&#xe9; M., Cacabelos D., Cassany&#xe9; A., Lanau-Angulo L., Boada J., Serrano J.C., Gonz&#xe1;lez C., et al. Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism. J. Neurochem. 2012;123:622&#x2013;634. doi: 10.1111/j.1471-4159.2012.07934.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2012.07934.x</ArticleId><ArticleId IdType="pubmed">22924648</ArticleId></ArticleIdList></Reference><Reference><Citation>Paliogiannis P., Fois A.G., Sotgia S., Mangoni A.A., Zinellu E., Pirina P., Carru C., Zinellu A. Circulating malondialdehyde concentrations in patients with stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. Biomark. Med. 2018;12:771&#x2013;781. doi: 10.2217/bmm-2017-0420.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2017-0420</ArticleId><ArticleId IdType="pubmed">29865860</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell B.R., Friedmann Angeli J.P., Bayir H., Bush A.I., Conrad M., Dixon S.J., Fulda S., Gasc&#xf3;n S., Hatzios S.K., Kagan V.E., et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017;71:273&#x2013;285. doi: 10.1016/j.cell.2017.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.09.021</ArticleId><ArticleId IdType="pmc">PMC5685180</ArticleId><ArticleId IdType="pubmed">28985560</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia M., Qin D., Zhao C., Chai L., Yu Z., Wang W., Tong L., Lv L., Wang Y., Rehwinkel J., et al. Redox homeostasis maintained by GPX4 facilitates STING activation. Nat. Immunol. 2020;21:727&#x2013;735. doi: 10.1038/s41590-020-0699-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0699-0</ArticleId><ArticleId IdType="pubmed">32541831</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H.T., Al-Hadrawi D.S., Almulla A.F., Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: A proof of concept and mechanism study. Mol. Psychiatry. 2022;24:1&#x2013;15. doi: 10.1038/s41380-022-01836-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila-Nava A., Pech-Aguilar A.G., Lugo R., Medina-Vera I., Guevara-Cruz M., Guti&#xe9;rrez-Solis A.L. Oxidative Stress Biomarkers and Their Association with Mortality among Patients Infected with SARS-CoV-2 in Mexico. Oxid. Med. Cell. Longev. 2022;17:1058813. doi: 10.1155/2022/1058813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/1058813</ArticleId><ArticleId IdType="pmc">PMC9210126</ArticleId><ArticleId IdType="pubmed">35746958</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Fern&#xe1;ndez M., Aller R., Heredia-Rodr&#xed;guez M., G&#xf3;mez-S&#xe1;nchez E., Mart&#xed;nez-Paz P., Gonzalo-Benito H., S&#xe1;nchez-de Prada L., Gorgojo &#xd3;., Carnicero-Frutos I., Tamayo E., et al. Lipid peroxidation as a hallmark of severity in COVID-19 patients. Redox Biol. 2021;48:102181. doi: 10.1016/j.redox.2021.102181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102181</ArticleId><ArticleId IdType="pmc">PMC8572041</ArticleId><ArticleId IdType="pubmed">34768063</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: A prospective observational study. Lancet Respir. Med. 2022;10:761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., O&#x2019;Hara M.E., Akrami A., Perego E., Olliaro P., Needham D.M. Long COVID: Aiming for a consensus. Lancet Respir. Med. 2022;10:632&#x2013;634. doi: 10.1016/S2213-2600(22)00135-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00135-7</ArticleId><ArticleId IdType="pmc">PMC9067938</ArticleId><ArticleId IdType="pubmed">35525253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang F., Shen Y., Zhang X., Cen Y., Wang B., Zhao S., Zhou Y., Hu B., Wang M., et al. Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge from Hospitals in Wuhan, China. JAMA Netw. Open. 2021;4:e2127403. doi: 10.1001/jamanetworkopen.2021.27403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T., Varnai R., Schranz D., Zavori L., Peterfi Z., Sipos D., T&#x151;k&#xe9;s-F&#xfc;zesi M., Illes Z., Buki A., Csecsei P. Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms. J. Clin. Med. 2021;10:4337. doi: 10.3390/jcm10194337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194337</ArticleId><ArticleId IdType="pmc">PMC8509483</ArticleId><ArticleId IdType="pubmed">34640355</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh. K., Larsen T.G., Hansen C.B., Hasselbalch R.B., Eriksen A.R.R., Bundgaard H., Frikke-Schmidt R., Hilsted L.M., &#xd8;stergaard L., Johansen I.S., et al. Self-Reported Long COVID and Its Association with the Presence of SARS-CoV-2 Antibodies in a Danish Cohort up to 12 Months after Infection. Microbiol. Spectr. 2022;10:e0253722. doi: 10.1128/spectrum.02537-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02537-22</ArticleId><ArticleId IdType="pmc">PMC9769646</ArticleId><ArticleId IdType="pubmed">36350150</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas S.K. Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? Oxid. Med. Cell. Longev. 2016;2016:5698931. doi: 10.1155/2016/5698931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/5698931</ArticleId><ArticleId IdType="pmc">PMC4736408</ArticleId><ArticleId IdType="pubmed">26881031</ArticleId></ArticleIdList></Reference><Reference><Citation>Jov&#xe9; M., Mota-Martorell N., Pradas I., Mart&#xed;n-Gari M., Ayala V., Pamplona R. The Advanced Lipoxidation End-Product Malondialdehyde-Lysine in Aging and Longevity. Antioxidants. 2020;9:1132. doi: 10.3390/antiox9111132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9111132</ArticleId><ArticleId IdType="pmc">PMC7696601</ArticleId><ArticleId IdType="pubmed">33203089</ArticleId></ArticleIdList></Reference><Reference><Citation>Laforge M., Elbim C., Fr&#xe8;re C., H&#xe9;madi M., Massaad C., Nuss P., Benoliel J.J., Becker C. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat. Rev. Immunol. 2020;20:515&#x2013;516. doi: 10.1038/s41577-020-0407-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0407-1</ArticleId><ArticleId IdType="pmc">PMC7388427</ArticleId><ArticleId IdType="pubmed">32728221</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;23:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson R.W., Brown R.L., Benjamin L., Nortley R., Wiethoff S., Bharucha T., Jayaseelan D.L., Kumar G., Raftopoulos R.E., Zambreanu L., et al. The emerging spectrum of COVID-19 neurology: Clinical, radiological and laboratory findings. Brain. 2020;143:3104&#x2013;3120. doi: 10.1093/brain/awaa240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V., Amiri M., Lebech A.M., Roed C., Mens H., Russell L., Fonsmark L., Berntsen M., Sigurdsson S.T., Carlsen J., et al. Central and peripheral nervous system complications of COVID-19: A prospective tertiary center cohort with 3-month follow-up. J. Neurol. 2021;268:3086&#x2013;3104. doi: 10.1007/s00415-020-10380-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10380-x</ArticleId><ArticleId IdType="pmc">PMC7803470</ArticleId><ArticleId IdType="pubmed">33438076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucchese G., Vogelgesang A., Boesl F., Raafat D., Holtfreter S., Br&#xf6;ker B.M., Stufano A., Fleischmann R., Pr&#xfc;ss H., Franke C., et al. Anti-neuronal antibodies against brainstem antigens are associated with COVID-19. EBioMedicine. 2022;83:104211. doi: 10.1016/j.ebiom.2022.104211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104211</ArticleId><ArticleId IdType="pmc">PMC9365397</ArticleId><ArticleId IdType="pubmed">35963198</ArticleId></ArticleIdList></Reference><Reference><Citation>Plantone D., Locci S., Bergantini L., Manco C., Cortese R., Meocci M., Cavallaro D., d&#x2019;Alessandro M., Bargagli E., De Stefano N. Brain neuronal and glialdamageduring acute COVID-19 infection in absence of clinical neurologicalmanifestations. J. Neurol. Neurosurg. Psychiatry. 2022;93:1343&#x2013;1348.</Citation><ArticleIdList><ArticleId IdType="pubmed">36137741</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B.D., Lemle M.D., Komaroff A.L., Snyder S.H. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Loconsole D., Centrone F., Morcavallo C., Campanella S., Sallustio A., Accogli M., Fortunato F., Parisi A., Chironna M. Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020&#x2013;March 2021) Int. J. Environ. Res. Public Health. 2021;18:4766. doi: 10.3390/ijerph18094766.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18094766</ArticleId><ArticleId IdType="pmc">PMC8125211</ArticleId><ArticleId IdType="pubmed">33947087</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Treatment Guidelines Panel  . Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health; Bethesda, MD, USA: 2021.  [(accessed on 2 April 2022)].  Available online:  https://www.covid19treatmentguidelines.nih.gov/</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Stufano A., Lucchese G., Stahl B., Grattagliano I., Dassisti L., Lovreglio P., Fl&#xf6;el A., Iavicoli I. Impact of COVID-19 emergency on the psychological well-being of susceptible individuals. Sci. Rep. 2022;12:11152. doi: 10.1038/s41598-022-15357-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15357-6</ArticleId><ArticleId IdType="pmc">PMC9247931</ArticleId><ArticleId IdType="pubmed">35778530</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonocore G., Perrone S., Longini M., Terzuoli L., Bracci R. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr. Res. 2000;47:221&#x2013;2244. doi: 10.1203/00006450-200002000-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/00006450-200002000-00012</ArticleId><ArticleId IdType="pubmed">10674350</ArticleId></ArticleIdList></Reference><Reference><Citation>Isgr&#xf2; C., Spagnuolo L., Pannucci E., Mondello L., Santi L., Dugo L., Sardanelli A.M. Rhus Coriaria L. Extract: Antioxidant Effect and Modulation of Bioenergetic Capacity in Fibroblasts from Parkinson&#x2019;s Disease Patients and THP-1 Macrophages. Int. J. Mol. Sci. 2022;23:12774. doi: 10.3390/ijms232112774.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232112774</ArticleId><ArticleId IdType="pmc">PMC9655332</ArticleId><ArticleId IdType="pubmed">36361562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Xia S.T., Tang Q., Wu J., Zhu X. A Novel Consistent Random Forest Framework: Bernoulli Random Forests. IEEE Trans. Neural Netw. Learn. Syst. 2018;29:3510&#x2013;3523.</Citation><ArticleIdList><ArticleId IdType="pubmed">28816676</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>